US5002772A
(en)
*
|
1988-05-31 |
1991-03-26 |
Pfizer Inc. |
Gastric retention system for controlled drug release
|
NZ228382A
(en)
*
|
1989-03-17 |
1992-08-26 |
Carter Holt Harvey Plastic Pro |
Drug administering coil-like device for insertion in body cavity of animal
|
JPH03163011A
(ja)
*
|
1989-08-31 |
1991-07-15 |
Yamanouchi Pharmaceut Co Ltd |
胃内滞留デバイス
|
US6361795B1
(en)
*
|
1989-09-05 |
2002-03-26 |
Alza Corporation |
Method for lowering blood glucose
|
US5091190A
(en)
*
|
1989-09-05 |
1992-02-25 |
Alza Corporation |
Delivery system for administration blood-glucose lowering drug
|
US5591454A
(en)
*
|
1989-09-05 |
1997-01-07 |
Alza Corporation |
Method for lowering blood glucose
|
US5024843A
(en)
*
|
1989-09-05 |
1991-06-18 |
Alza Corporation |
Oral hypoglycemic glipizide granulation
|
US5922342A
(en)
*
|
1990-10-01 |
1999-07-13 |
Pharmacia & Upjohn Company |
Lateral edge coated controlled release pharmaceutical compositions
|
US5232704A
(en)
*
|
1990-12-19 |
1993-08-03 |
G. D. Searle & Co. |
Sustained release, bilayer buoyant dosage form
|
EP0988838B1
(en)
*
|
1995-03-23 |
2003-05-21 |
Advanced Animal Technology Limited |
Substance delivery device
|
US5683718A
(en)
*
|
1995-04-04 |
1997-11-04 |
Time-Cap Labs, Inc. |
Enteric coated tablet with raised identification character and method of manufacture
|
DE69828289T2
(de)
*
|
1997-08-11 |
2005-06-02 |
Alza Corp., Mountain View |
Dosierungsform für verzögerte Freisetzung eines Wirkstoffs
|
IN186245B
(ko)
|
1997-09-19 |
2001-07-14 |
Ranbaxy Lab Ltd |
|
US6635281B2
(en)
|
1998-12-23 |
2003-10-21 |
Alza Corporation |
Gastric retaining oral liquid dosage form
|
US6797283B1
(en)
|
1998-12-23 |
2004-09-28 |
Alza Corporation |
Gastric retention dosage form having multiple layers
|
US7815590B2
(en)
|
1999-08-05 |
2010-10-19 |
Broncus Technologies, Inc. |
Devices for maintaining patency of surgically created channels in tissue
|
IL133196A0
(en)
|
1999-11-29 |
2001-03-19 |
Yissum Res Dev Co |
Gastroretentive controlled release pharmaceutical dosage forms
|
DE10014588A1
(de)
|
2000-03-27 |
2001-10-04 |
Basf Ag |
Wirkstoffhaltige Schwimmformen enthaltend Polyvinylacetat und Polyvinylpyrrolidon, deren Verwendung und Herstellung
|
US7674480B2
(en)
*
|
2000-06-23 |
2010-03-09 |
Teva Pharmaceutical Industries Ltd. |
Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
|
EP1245227A1
(en)
*
|
2001-03-31 |
2002-10-02 |
Jagotec Ag |
A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same
|
US7708712B2
(en)
*
|
2001-09-04 |
2010-05-04 |
Broncus Technologies, Inc. |
Methods and devices for maintaining patency of surgically created channels in a body organ
|
US20050060041A1
(en)
*
|
2001-09-04 |
2005-03-17 |
Broncus Technologies, Inc. |
Methods and devices for maintaining surgically created channels in a body organ
|
US20030050648A1
(en)
|
2001-09-11 |
2003-03-13 |
Spiration, Inc. |
Removable lung reduction devices, systems, and methods
|
NZ514279A
(en)
*
|
2001-09-20 |
2004-02-27 |
Ashmont Holdings Ltd |
Intraruminal device for dispensing medication where device has arms that open to keep the device in the animal's rumen after a constraint device dissolves
|
US20060159743A1
(en)
*
|
2001-10-25 |
2006-07-20 |
Depomed, Inc. |
Methods of treating non-nociceptive pain states with gastric retentive gabapentin
|
US6592594B2
(en)
*
|
2001-10-25 |
2003-07-15 |
Spiration, Inc. |
Bronchial obstruction device deployment system and method
|
US20030104052A1
(en)
*
|
2001-10-25 |
2003-06-05 |
Bret Berner |
Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
|
CA2409552A1
(en)
|
2001-10-25 |
2003-04-25 |
Depomed, Inc. |
Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
|
TWI312285B
(en)
|
2001-10-25 |
2009-07-21 |
Depomed Inc |
Methods of treatment using a gastric retained gabapentin dosage
|
US20030091630A1
(en)
*
|
2001-10-25 |
2003-05-15 |
Jenny Louie-Helm |
Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
|
US7612112B2
(en)
|
2001-10-25 |
2009-11-03 |
Depomed, Inc. |
Methods of treatment using a gastric retained gabapentin dosage
|
US6929637B2
(en)
*
|
2002-02-21 |
2005-08-16 |
Spiration, Inc. |
Device and method for intra-bronchial provision of a therapeutic agent
|
US20030181922A1
(en)
|
2002-03-20 |
2003-09-25 |
Spiration, Inc. |
Removable anchored lung volume reduction devices and methods
|
US20030216769A1
(en)
|
2002-05-17 |
2003-11-20 |
Dillard David H. |
Removable anchored lung volume reduction devices and methods
|
AU2003282603A1
(en)
*
|
2002-10-11 |
2004-05-04 |
Depomed Development Ltd |
Gastro-retentive levodopa delivery form
|
US7485322B2
(en)
*
|
2002-12-24 |
2009-02-03 |
Lek Pharmaceuticals D.D. |
Modified release pharmaceutical composition
|
US7100616B2
(en)
|
2003-04-08 |
2006-09-05 |
Spiration, Inc. |
Bronchoscopic lung volume reduction method
|
US7554452B2
(en)
*
|
2003-07-18 |
2009-06-30 |
Cary Cole |
Ingestible tracking and locating device
|
US8002740B2
(en)
|
2003-07-18 |
2011-08-23 |
Broncus Technologies, Inc. |
Devices for maintaining patency of surgically created channels in tissue
|
US8308682B2
(en)
|
2003-07-18 |
2012-11-13 |
Broncus Medical Inc. |
Devices for maintaining patency of surgically created channels in tissue
|
US7533671B2
(en)
|
2003-08-08 |
2009-05-19 |
Spiration, Inc. |
Bronchoscopic repair of air leaks in a lung
|
DE102004031014A1
(de)
*
|
2004-06-26 |
2006-01-12 |
Raumedic Ag |
Vorrichtung zur gezielten Freistzung von Stoffen in einem Hohlraum
|
US8409167B2
(en)
|
2004-07-19 |
2013-04-02 |
Broncus Medical Inc |
Devices for delivering substances through an extra-anatomic opening created in an airway
|
IL166183A0
(en)
*
|
2005-01-06 |
2006-01-15 |
Yissum Res Dev Co |
Novel diagnostic and imaging techniques of the gi tract
|
JP2008526461A
(ja)
*
|
2005-01-19 |
2008-07-24 |
センティネル・グループ・エルエルシー |
薬剤送達システム及び方法
|
EP3827747A1
(en)
|
2005-04-28 |
2021-06-02 |
Otsuka Pharmaceutical Co., Ltd. |
Pharma-informatics system
|
US8730031B2
(en)
|
2005-04-28 |
2014-05-20 |
Proteus Digital Health, Inc. |
Communication system using an implantable device
|
US8802183B2
(en)
|
2005-04-28 |
2014-08-12 |
Proteus Digital Health, Inc. |
Communication system with enhanced partial power source and method of manufacturing same
|
US8912908B2
(en)
|
2005-04-28 |
2014-12-16 |
Proteus Digital Health, Inc. |
Communication system with remote activation
|
US8836513B2
(en)
|
2006-04-28 |
2014-09-16 |
Proteus Digital Health, Inc. |
Communication system incorporated in an ingestible product
|
US9198608B2
(en)
|
2005-04-28 |
2015-12-01 |
Proteus Digital Health, Inc. |
Communication system incorporated in a container
|
US8216266B2
(en)
*
|
2005-06-16 |
2012-07-10 |
Hively Robert L |
Gastric bariatric apparatus with selective inflation and safety features
|
WO2007013059A2
(en)
*
|
2005-07-26 |
2007-02-01 |
Ram Weiss |
Extending intrabody capsule
|
US8021384B2
(en)
*
|
2005-07-26 |
2011-09-20 |
Ram Weiss |
Extending intrabody capsule
|
JP5714210B2
(ja)
|
2005-09-01 |
2015-05-07 |
プロテウス デジタル ヘルス, インコーポレイテッド |
移植可能なワイヤ無し通信システム
|
US20090176882A1
(en)
|
2008-12-09 |
2009-07-09 |
Depomed, Inc. |
Gastric retentive gabapentin dosage forms and methods for using same
|
US7691151B2
(en)
|
2006-03-31 |
2010-04-06 |
Spiration, Inc. |
Articulable Anchor
|
US9011930B2
(en)
*
|
2006-05-01 |
2015-04-21 |
Zycal Bioceuticals Healthcare Company, Inc. |
Nutritional supplement and use thereof
|
JP2009544338A
(ja)
|
2006-05-02 |
2009-12-17 |
プロテウス バイオメディカル インコーポレイテッド |
患者に合わせてカスタマイズした治療レジメン
|
US20080020037A1
(en)
*
|
2006-07-11 |
2008-01-24 |
Robertson Timothy L |
Acoustic Pharma-Informatics System
|
RU2420268C2
(ru)
*
|
2006-09-04 |
2011-06-10 |
Панацея Биотек Лимитед |
Способ программируемой плавучей доставки
|
EP2083680B1
(en)
|
2006-10-25 |
2016-08-10 |
Proteus Digital Health, Inc. |
Controlled activation ingestible identifier
|
EP2069004A4
(en)
|
2006-11-20 |
2014-07-09 |
Proteus Digital Health Inc |
PERSONAL HEALTH SIGNAL RECEIVERS WITH ACTIVE SIGNAL PROCESSING
|
CA2672602C
(en)
*
|
2006-12-18 |
2014-05-20 |
Electronic Dietary Foods Inc. |
Device for delivery of a substance
|
ES2930588T3
(es)
|
2007-02-01 |
2022-12-19 |
Otsuka Pharma Co Ltd |
Sistemas de marcador de eventos ingeribles
|
KR101528748B1
(ko)
|
2007-02-14 |
2015-06-15 |
프로테우스 디지털 헬스, 인코포레이티드 |
고 표면적 전극을 갖는 체내 전원
|
EP2124725A1
(en)
|
2007-03-09 |
2009-12-02 |
Proteus Biomedical, Inc. |
In-body device having a multi-directional transmitter
|
US9270025B2
(en)
|
2007-03-09 |
2016-02-23 |
Proteus Digital Health, Inc. |
In-body device having deployable antenna
|
US20080287371A1
(en)
*
|
2007-05-17 |
2008-11-20 |
Tranzyme Pharma Inc. |
Macrocyclic antagonists of the motilin receptor for modulation of the migrating motor complex
|
US8115618B2
(en)
|
2007-05-24 |
2012-02-14 |
Proteus Biomedical, Inc. |
RFID antenna for in-body device
|
FI2192946T3
(fi)
|
2007-09-25 |
2022-11-30 |
|
Elimistön sisäinen laite, jossa on virtuaalinen dipolisignaalinvahvistus
|
KR101586193B1
(ko)
|
2007-11-27 |
2016-01-18 |
프로테우스 디지털 헬스, 인코포레이티드 |
통신 채널을 이용한 트랜스바디 통신 시스템
|
AU2009221781B2
(en)
|
2008-03-05 |
2014-12-11 |
Otsuka Pharmaceutical Co., Ltd. |
Multi-mode communication ingestible event markers and systems, and methods of using the same
|
DE102008002397A1
(de)
|
2008-06-12 |
2009-12-17 |
Biotronik Vi Patent Ag |
Implantierbare Vorrichtung
|
MY154234A
(en)
|
2008-07-08 |
2015-05-15 |
Proteus Digital Health Inc |
Ingestible event marker data framework
|
US8287902B2
(en)
*
|
2008-07-23 |
2012-10-16 |
Rainbow Medical Ltd. |
Enhanced-diffusion capsule
|
AU2009281876B2
(en)
|
2008-08-13 |
2014-05-22 |
Proteus Digital Health, Inc. |
Ingestible circuitry
|
WO2010019915A1
(en)
|
2008-08-15 |
2010-02-18 |
Depomed Inc. |
Gastric retentive pharmaceutical compositions for treatment and prevention of cns disorders
|
US8055334B2
(en)
|
2008-12-11 |
2011-11-08 |
Proteus Biomedical, Inc. |
Evaluation of gastrointestinal function using portable electroviscerography systems and methods of using the same
|
WO2013012869A1
(en)
|
2011-07-21 |
2013-01-24 |
Proteus Digital Health, Inc. |
Mobile communication device, system, and method
|
EP3395333A1
(en)
|
2009-01-06 |
2018-10-31 |
Proteus Digital Health, Inc. |
Pharmaceutical dosages delivery system
|
JP2012514799A
(ja)
|
2009-01-06 |
2012-06-28 |
プロテウス バイオメディカル インコーポレイテッド |
摂取に関連するバイオフィードバックおよび個別薬物療法の方法およびシステム
|
WO2010111403A2
(en)
|
2009-03-25 |
2010-09-30 |
Proteus Biomedical, Inc. |
Probablistic pharmacokinetic and pharmacodynamic modeling
|
CN102458236B
(zh)
|
2009-04-28 |
2016-01-27 |
普罗秋斯数字健康公司 |
高可靠性的可摄入事件标记器及其使用方法
|
US9149423B2
(en)
|
2009-05-12 |
2015-10-06 |
Proteus Digital Health, Inc. |
Ingestible event markers comprising an ingestible component
|
EA023156B1
(ru)
*
|
2009-06-26 |
2016-04-29 |
ТАРИС Биомедикал ЛЛК |
Устройство для доставки лекарств
|
US8558563B2
(en)
|
2009-08-21 |
2013-10-15 |
Proteus Digital Health, Inc. |
Apparatus and method for measuring biochemical parameters
|
TWI517050B
(zh)
|
2009-11-04 |
2016-01-11 |
普羅托斯數位健康公司 |
供應鏈管理之系統
|
US9421169B2
(en)
*
|
2009-11-20 |
2016-08-23 |
Covidien Lp |
Oral dosage forms for delivery of therapeutic agents
|
UA109424C2
(uk)
|
2009-12-02 |
2015-08-25 |
|
Фармацевтичний продукт, фармацевтична таблетка з електронним маркером і спосіб виготовлення фармацевтичної таблетки
|
WO2011111068A2
(en)
|
2010-03-09 |
2011-09-15 |
Council Of Scientific And Industrial Research |
Gastroretentive, extended release composition of therapeutic agent
|
BR112012025650A2
(pt)
|
2010-04-07 |
2020-08-18 |
Proteus Digital Health, Inc. |
dispositivo ingerível miniatura
|
TWI557672B
(zh)
|
2010-05-19 |
2016-11-11 |
波提亞斯數位康健公司 |
用於從製造商跟蹤藥物直到患者之電腦系統及電腦實施之方法、用於確認將藥物給予患者的設備及方法、患者介面裝置
|
JP2014504902A
(ja)
|
2010-11-22 |
2014-02-27 |
プロテウス デジタル ヘルス, インコーポレイテッド |
医薬品を有する摂取可能なデバイス
|
WO2012158530A1
(en)
|
2011-05-13 |
2012-11-22 |
Broncus Technologies, Inc. |
Methods and devices for ablation of tissue
|
US8709034B2
(en)
|
2011-05-13 |
2014-04-29 |
Broncus Medical Inc. |
Methods and devices for diagnosing, monitoring, or treating medical conditions through an opening through an airway wall
|
US8858963B1
(en)
|
2011-05-17 |
2014-10-14 |
Mallinckrodt Llc |
Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia
|
US9050335B1
(en)
|
2011-05-17 |
2015-06-09 |
Mallinckrodt Llc |
Pharmaceutical compositions for extended release of oxycodone and acetaminophen resulting in a quick onset and prolonged period of analgesia
|
US9756874B2
(en)
|
2011-07-11 |
2017-09-12 |
Proteus Digital Health, Inc. |
Masticable ingestible product and communication system therefor
|
WO2015112603A1
(en)
|
2014-01-21 |
2015-07-30 |
Proteus Digital Health, Inc. |
Masticable ingestible product and communication system therefor
|
US9235683B2
(en)
|
2011-11-09 |
2016-01-12 |
Proteus Digital Health, Inc. |
Apparatus, system, and method for managing adherence to a regimen
|
WO2013078235A1
(en)
|
2011-11-23 |
2013-05-30 |
Broncus Medical Inc |
Methods and devices for diagnosing, monitoring, or treating medical conditions through an opening through an airway wall
|
US20130143867A1
(en)
|
2011-12-02 |
2013-06-06 |
Sychroneuron Inc. |
Acamprosate formulations, methods of using the same, and combinations comprising the same
|
US9271897B2
(en)
|
2012-07-23 |
2016-03-01 |
Proteus Digital Health, Inc. |
Techniques for manufacturing ingestible event markers comprising an ingestible component
|
SG11201503027SA
(en)
|
2012-10-18 |
2015-05-28 |
Proteus Digital Health Inc |
Apparatus, system, and method to adaptively optimize power dissipation and broadcast power in a power source for a communication device
|
JP2016508529A
(ja)
|
2013-01-29 |
2016-03-22 |
プロテウス デジタル ヘルス, インコーポレイテッド |
高度に膨張可能なポリマーフィルムおよびこれを含む組成物
|
JP5941240B2
(ja)
|
2013-03-15 |
2016-06-29 |
プロテウス デジタル ヘルス, インコーポレイテッド |
金属検出器装置、システム、および方法
|
US11744481B2
(en)
|
2013-03-15 |
2023-09-05 |
Otsuka Pharmaceutical Co., Ltd. |
System, apparatus and methods for data collection and assessing outcomes
|
EP3003297A4
(en)
|
2013-06-05 |
2017-04-19 |
Synchroneuron Inc. |
Acamprosate formulations, methods of using the same, and combinations comprising the same
|
US9796576B2
(en)
|
2013-08-30 |
2017-10-24 |
Proteus Digital Health, Inc. |
Container with electronically controlled interlock
|
US10084880B2
(en)
|
2013-11-04 |
2018-09-25 |
Proteus Digital Health, Inc. |
Social media networking based on physiologic information
|
JP6570043B2
(ja)
*
|
2014-06-02 |
2019-09-04 |
クレシオ・バイオサイエンシズ・リミテッド |
膨張性胃内滞留型剤形
|
MX2016016406A
(es)
*
|
2014-06-11 |
2017-10-12 |
Massachusetts Inst Technology |
Estructuras de permanencia, y métodos relacionados.
|
US20170266112A1
(en)
|
2014-06-11 |
2017-09-21 |
Massachusetts Institute Of Technology |
Residence structures and related methods
|
US9492396B2
(en)
|
2014-07-15 |
2016-11-15 |
Yossi Gross |
Enhanced drug delivery pill
|
US9617230B2
(en)
|
2014-12-22 |
2017-04-11 |
Farmington Pharma Development |
Creatine prodrugs, compositions and methods of use thereof
|
US10953208B2
(en)
|
2015-05-01 |
2021-03-23 |
Massachusetts Institute Of Technology |
Triggerable shape memory induction devices
|
US11051543B2
(en)
|
2015-07-21 |
2021-07-06 |
Otsuka Pharmaceutical Co. Ltd. |
Alginate on adhesive bilayer laminate film
|
EP3364946A4
(en)
|
2015-10-23 |
2019-06-26 |
Lyndra, Inc. |
STOMACH DISTRIBUTION SYSTEMS FOR DELAYED RELEASE OF THERAPEUTIC ACTIVE SUBSTANCES AND METHOD FOR THEIR USE
|
CA3006999A1
(en)
*
|
2015-12-01 |
2017-06-08 |
Clexio Biosciences Ltd. |
Gastric retentive devices
|
AU2016362794B2
(en)
*
|
2015-12-02 |
2019-05-09 |
Clexio Biosciences Ltd. |
Device for preparing gastroretentive dosage forms
|
EP4302817A3
(en)
*
|
2015-12-08 |
2024-02-21 |
Lyndra Therapeutics, Inc. |
Geometric configurations for gastric residence systems
|
CA3025650A1
(en)
*
|
2016-05-27 |
2017-11-30 |
Lyndra, Inc. |
Materials architecture for gastric residence systems
|
KR102051875B1
(ko)
|
2016-07-22 |
2019-12-04 |
프로테우스 디지털 헬스, 인코포레이티드 |
섭취 가능한 이벤트 마커의 전자기 감지 및 검출
|
AU2017336154B2
(en)
*
|
2016-09-30 |
2023-11-09 |
Lyndra Therapeutics, Inc. |
Gastric residence systems for sustained delivery of adamantane-class drugs
|
EP3531901A4
(en)
|
2016-10-26 |
2021-01-27 |
Proteus Digital Health, Inc. |
CAPSULE PREPARATION PROCESSES WITH INGERABLE EVENT MARKERS
|
EP3547974B1
(en)
|
2016-12-02 |
2023-11-15 |
Clexio Biosciences Ltd. |
Gastric residence system
|
IL301683A
(en)
|
2017-05-17 |
2023-05-01 |
Massachusetts Inst Technology |
Self-healing systems and related components and methods
|
US11541015B2
(en)
|
2017-05-17 |
2023-01-03 |
Massachusetts Institute Of Technology |
Self-righting systems, methods, and related components
|
CN107161363B
(zh)
*
|
2017-05-27 |
2018-10-26 |
芜湖思科生产力促进中心有限公司 |
一种物料的均分装箱装置
|
US11793751B2
(en)
|
2017-09-20 |
2023-10-24 |
Lyndra Therapeutics, Inc. |
Encapsulation of gastric residence systems
|
IL274701B1
(en)
|
2017-12-01 |
2024-03-01 |
Ultragenyx Pharmaceutical Inc |
Promote drugs, compositions and methods of their use
|
JP7296084B2
(ja)
*
|
2017-12-04 |
2023-06-22 |
クレキシオ バイオサイエンシーズ エルティーディー. |
長時間作用型胃滞留システム
|
AU2019269636A1
(en)
|
2018-05-17 |
2020-11-19 |
Massachusetts Institute Of Technology |
Systems for electrical stimulation
|
CN114191307A
(zh)
|
2020-09-17 |
2022-03-18 |
上海汉都医药科技有限公司 |
一种口腔滞留装置及其制备方法
|
CN112118886B
(zh)
|
2018-05-23 |
2022-08-23 |
上海汉都医药科技有限公司 |
活性药物成分的控释系统及其制备方法
|
US11911513B2
(en)
|
2018-05-23 |
2024-02-27 |
Shanghai Wd Pharmaceutical Co., Ltd |
Controlled-release system of active pharmaceutical ingredient and preparation method therefor
|
WO2019232291A1
(en)
|
2018-05-31 |
2019-12-05 |
Massachusetts Institute Of Technology |
Drug delivery articles for gram-level dosing
|
US10675248B2
(en)
|
2018-08-14 |
2020-06-09 |
Alma Therapeutics Ltd. |
Expandable pill
|
AU2019380225A1
(en)
*
|
2018-11-15 |
2020-11-26 |
Massachusetts Institute Of Technology |
Actuating components and related methods
|
US11771829B2
(en)
|
2019-02-01 |
2023-10-03 |
Massachusetts Institute Of Technology |
Systems and methods for liquid injection
|
US11389398B2
(en)
|
2019-05-14 |
2022-07-19 |
Clexio Biosciences Ltd. |
Gastroretentive treatment of nocturnal symptoms and morning akinesia in subjects with parkinson's disease
|
AU2020379040A1
(en)
*
|
2019-11-08 |
2022-06-09 |
Lyndra Therapeutics, Inc. |
Gastric residence systems having a filament for improved gastric residence
|
US11541216B2
(en)
|
2019-11-21 |
2023-01-03 |
Massachusetts Institute Of Technology |
Methods for manufacturing tissue interfacing components
|
EP4188508A2
(en)
*
|
2020-07-30 |
2023-06-07 |
Verily Life Sciences LLC |
Pill with needle delivery system having outwardly expanding mechanical actuation
|
CA3192658A1
(en)
*
|
2020-09-16 |
2022-03-24 |
Eric Gustin HASSENPFLUG |
Oral drug delivery device with expanding band
|
KR20230098628A
(ko)
*
|
2020-10-30 |
2023-07-04 |
트리아스텍 인코포레이티드 |
위장관 약학적 제형
|
CA3201057A1
(en)
|
2020-12-08 |
2022-06-16 |
Mark Christopher LAY |
Improvements to devices and methods for delivery of substances to animals
|
WO2022195476A1
(en)
|
2021-03-15 |
2022-09-22 |
Clexio Biosciences Ltd. |
Gastroretentive devices for assessment of intragastric conditions
|
EP4209208A1
(en)
*
|
2022-01-06 |
2023-07-12 |
ETH Zurich |
Swallowable, self-expandable drug delivery device and uses thereof
|
WO2023141524A2
(en)
*
|
2022-01-19 |
2023-07-27 |
Lyndra Therapeutics, Inc. |
Dosage forms for gastric retention
|